 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 03/17/2023 |
$35.16 |
$35.31 |
$32.72 |
$33.22 |
2.05M | | 03/20/2023 |
$33.00 |
$33.19 |
$31.90 |
$32.23 |
744.30K | | 03/21/2023 |
$32.29 |
$32.97 |
$31.93 |
$32.40 |
625.10K | | 03/22/2023 |
$32.42 |
$32.53 |
$30.58 |
$30.67 |
1.06M | | 03/23/2023 |
$31.05 |
$31.79 |
$29.60 |
$30.34 |
1.25M |
|
|
| Beam Therapeutics is a biotechnology company. Co. has identified four development candidates to date: three from its ex vivo platform, with two candidates targeting hemoglobinopathies and one candidate targeting T-cell leukemia, and one from its in vivo platform targeting glycogen storage disease. BEAM-102 directly corrects the causative mutation in sickle cell disease by recreating a naturally-occurring normal human hemoglobin variant, HbG-Makassar. BEAM-201 is an anti-CD7, multiplex edited, allogeneic chimeric antigen receptor T cell development candidate for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. | |
|
Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on March 17, 2023, BEAM opened at $35.16, traded as high as $35.31 and as low as $32.72, and closed at $33.22. Trading volume was a total of 2.05M shares. On March 20, 2023, BEAM opened at $33.00, traded as high as $33.19 and as low as $31.90, and closed at $32.23. Trading volume was a total of 744.30K shares. On March 21, 2023, BEAM opened at $32.29, traded as high as $32.97 and as low as $31.93, and closed at $32.40. Trading volume was a total of 625.10K shares. On March 22, 2023, BEAM opened at $32.42, traded as high as $32.53 and as low as $30.58, and closed at $30.67. Trading volume was a total of 1.06M shares. On March 23, 2023, BEAM opened at $31.05, traded as high as $31.79 and as low as $29.60, and closed at $30.34. Trading volume was a total of 1.25M shares.
BEAM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/06/2020 |
|
| End date: |
03/23/2023 |
|
| Start price/share: |
$18.75 |
|
| End price/share: |
$30.34 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
61.81% |
|
| Average Annual Total Return: |
16.66% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$16,181.42 |
|
| Years: |
3.12 |
|
|
|
| Date |
Close |
| 03/17/2023 | $33.22 | | 03/20/2023 | $32.23 | | 03/21/2023 | $32.40 | | 03/22/2023 | $30.67 | | 03/23/2023 | $30.34 |
|
|
Free BEAM Email Alerts:
